193 related articles for article (PubMed ID: 25447594)
21. Molecular mechanism of activation of the immunoregulatory amidase NAAA.
Gorelik A; Gebai A; Illes K; Piomelli D; Nagar B
Proc Natl Acad Sci U S A; 2018 Oct; 115(43):E10032-E10040. PubMed ID: 30301806
[TBL] [Abstract][Full Text] [Related]
22. Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors.
Malamas MS; Farah SI; Lamani M; Pelekoudas DN; Perry NT; Rajarshi G; Miyabe CY; Chandrashekhar H; West J; Pavlopoulos S; Makriyannis A
Bioorg Med Chem; 2020 Jan; 28(1):115195. PubMed ID: 31761726
[TBL] [Abstract][Full Text] [Related]
23. 2-pentadecyl-2-oxazoline: Identification in coffee, synthesis and activity in a rat model of carrageenan-induced hindpaw inflammation.
Impellizzeri D; Cordaro M; Bruschetta G; Crupi R; Pascali J; Alfonsi D; Marcolongo G; Cuzzocrea S
Pharmacol Res; 2016 Jun; 108():23-30. PubMed ID: 27083308
[TBL] [Abstract][Full Text] [Related]
24. Progress in the development of β-lactams as N-Acylethanolamine Acid Amidase (NAAA) inhibitors: Synthesis and SAR study of new, potent N-O-substituted derivatives.
Petracca R; Ponzano S; Bertozzi SM; Sasso O; Piomelli D; Bandiera T; Bertozzi F
Eur J Med Chem; 2017 Jan; 126():561-575. PubMed ID: 27915171
[TBL] [Abstract][Full Text] [Related]
25. Harnessing the anti-inflammatory potential of palmitoylethanolamide.
Alhouayek M; Muccioli GG
Drug Discov Today; 2014 Oct; 19(10):1632-9. PubMed ID: 24952959
[TBL] [Abstract][Full Text] [Related]
26. Effect of Ultra-Micronized-Palmitoylethanolamide and Acetyl-l-Carnitine on Experimental Model of Inflammatory Pain.
Ardizzone A; Fusco R; Casili G; Lanza M; Impellizzeri D; Esposito E; Cuzzocrea S
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671213
[TBL] [Abstract][Full Text] [Related]
27. The N-acylethanolamine-hydrolyzing acid amidase (NAAA).
Tsuboi K; Takezaki N; Ueda N
Chem Biodivers; 2007 Aug; 4(8):1914-25. PubMed ID: 17712833
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and structure-activity relationships of N-(2-oxo-3-oxetanyl)amides as N-acylethanolamine-hydrolyzing acid amidase inhibitors.
Solorzano C; Antonietti F; Duranti A; Tontini A; Rivara S; Lodola A; Vacondio F; Tarzia G; Piomelli D; Mor M
J Med Chem; 2010 Aug; 53(15):5770-81. PubMed ID: 20604568
[TBL] [Abstract][Full Text] [Related]
29. A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models.
Britti D; Crupi R; Impellizzeri D; Gugliandolo E; Fusco R; Schievano C; Morittu VM; Evangelista M; Di Paola R; Cuzzocrea S
BMC Vet Res; 2017 Aug; 13(1):229. PubMed ID: 28768536
[TBL] [Abstract][Full Text] [Related]
30. Synergic Therapeutic Potential of PEA-Um Treatment and NAAA Enzyme Silencing In the Management of Neuroinflammation.
Casili G; Lanza M; Campolo M; Siracusa R; Paterniti I; Ardizzone A; Scuderi SA; Cuzzocrea S; Esposito E
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050589
[TBL] [Abstract][Full Text] [Related]
31. Endogenous molecules stimulating N-acylethanolamine-hydrolyzing acid amidase (NAAA).
Tai T; Tsuboi K; Uyama T; Masuda K; Cravatt BF; Houchi H; Ueda N
ACS Chem Neurosci; 2012 May; 3(5):379-85. PubMed ID: 22860206
[TBL] [Abstract][Full Text] [Related]
32. Assay of NAAA Activity.
Tsuboi K; Ueda N
Methods Mol Biol; 2016; 1412():137-48. PubMed ID: 27245900
[TBL] [Abstract][Full Text] [Related]
33. N-acylethanolamine acid amidase (NAAA) inhibition decreases the motivation for alcohol in Marchigian Sardinian alcohol-preferring rats.
Fotio Y; Ciccocioppo R; Piomelli D
Psychopharmacology (Berl); 2021 Jan; 238(1):249-258. PubMed ID: 33037452
[TBL] [Abstract][Full Text] [Related]
34. An Important Role for N-Acylethanolamine Acid Amidase in the Complete Freund's Adjuvant Rat Model of Arthritis.
Bonezzi FT; Sasso O; Pontis S; Realini N; Romeo E; Ponzano S; Nuzzi A; Fiasella A; Bertozzi F; Piomelli D
J Pharmacol Exp Ther; 2016 Mar; 356(3):656-63. PubMed ID: 26769918
[TBL] [Abstract][Full Text] [Related]
35. Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase.
Tsuboi K; Sun YX; Okamoto Y; Araki N; Tonai T; Ueda N
J Biol Chem; 2005 Mar; 280(12):11082-92. PubMed ID: 15655246
[TBL] [Abstract][Full Text] [Related]
36. Design and synthesis of potent N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor as anti-inflammatory compounds.
Li Y; Yang L; Chen L; Zhu C; Huang R; Zheng X; Qiu Y; Fu J
PLoS One; 2012; 7(8):e43023. PubMed ID: 22916199
[TBL] [Abstract][Full Text] [Related]
37. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages.
Sun YX; Tsuboi K; Zhao LY; Okamoto Y; Lambert DM; Ueda N
Biochim Biophys Acta; 2005 Oct; 1736(3):211-20. PubMed ID: 16154384
[TBL] [Abstract][Full Text] [Related]
38. Activity-Based Probe for N-Acylethanolamine Acid Amidase.
Romeo E; Ponzano S; Armirotti A; Summa M; Bertozzi F; Garau G; Bandiera T; Piomelli D
ACS Chem Biol; 2015 Sep; 10(9):2057-2064. PubMed ID: 26102511
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, Molecular Modeling and Biological Evaluation of Metabolically Stable Analogues of the Endogenous Fatty Acid Amide Palmitoylethanolamide.
D'Aloia A; Arrigoni F; Tisi R; Palmioli A; Ceriani M; Artusa V; Airoldi C; Zampella G; Costa B; Cipolla L
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33260658
[TBL] [Abstract][Full Text] [Related]
40. Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis.
Migliore M; Pontis S; Fuentes de Arriba AL; Realini N; Torrente E; Armirotti A; Romeo E; Di Martino S; Russo D; Pizzirani D; Summa M; Lanfranco M; Ottonello G; Busquet P; Jung KM; Garcia-Guzman M; Heim R; Scarpelli R; Piomelli D
Angew Chem Int Ed Engl; 2016 Sep; 55(37):11193-11197. PubMed ID: 27404798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
